A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
Clinical trial NCT05945485 · COMPLETED
Trial details
- NCT number
- NCT05945485
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2026-05-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.